PD-L1 gene therapy (Pfizer/University of Florida/University of Michigan)

N/A

Report date: 2025/01/26 17:44:26

Base Information

Drug NamePD-L1 gene therapy (Pfizer/University of Florida/University of Michigan)
Drug Alias NamescAAV9-PD-L1 (Pfizer/University of Florida/University of Michigan)
ClassificationOther
Mechanisms of ActionProgrammed death-ligand 1 agonists
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsRejection in heart transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncUniversity Of MichiganUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsRejection in heart transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A